about
Understanding the role of the kynurenine pathway in human breast cancer immunobiologyAn Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer CellsNicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from PellagraSingle-shot characterization of enzymatic reaction constants Km and kcat by an acoustic-driven, bubble-based fast micromixer.A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease.Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity.Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesotheliomaTryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cellsDevelopment of 1-N-(11)C-Methyl-L- and -D-Tryptophan for pharmacokinetic imaging of the immune checkpoint inhibitor 1-Methyl-Tryptophan.The emerging roles of Oct4 in tumor-initiating cells.Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levelsZoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumorsPharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.Microenvironmental clues for glioma immunotherapy.Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.A Systematic Evaluation of Methods for Tailoring Genome-Scale Metabolic Models.Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells.Altered tryptophan metabolism in human meningioma.Quinolinic acid induces neuritogenesis in SH-SY5Y neuroblastoma cells independently of NMDA receptor activation.Use of high-performance liquid chromatography-tandem electrospray ionization mass spectrometry to assess the speciation of a ruthenium(III) anticancer drug in the cytosol of cancer cells.Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis.Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression.Effective synthesis of kynurenine-containing peptides via on-resin ozonolysis of tryptophan residues: synthesis of cyclomontanin B.Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation.HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
P2860
Q26773472-3A5D1A88-7CA5-4BF5-9A2A-9BEB79CA6BB9Q28547142-3E2AACF1-DB0B-4929-AC7E-E0E4E3AA3C5DQ28730781-8978C3BB-272F-4193-9CB4-4083133CE8FDQ30439935-046402A2-4791-42CD-80FE-45DC229773E9Q33592717-0046F41D-C9A9-4859-B2CD-03935AA0C620Q34546698-A8A73667-996E-4698-ACEB-9919CD5D1ED9Q35176037-5686D4C9-13DA-4774-B7BD-59A1EC1F5F79Q35813504-438F850D-B54B-49A5-A148-6473641DDAA7Q36265787-F92B10D4-53E9-422E-8B2F-0B442CB90A4FQ36498067-ED2B79D1-A876-4A11-B8E9-C0C3B945F10CQ37068001-1238A1BE-18E9-435A-8297-03DD41EF11CCQ37149502-50C92F1D-7CD5-41DC-9A7A-A1C61CEE7E40Q37190433-BDE8C981-C12A-4788-AA42-9F511401802CQ37457684-E7A42DE9-1B35-417F-B9D9-7E9A178CA2C0Q37687020-2C83F693-7254-4AC0-B7E2-DA5888D2F629Q38194054-79CC0586-ABF6-4F02-8846-8CDA37697550Q38571347-48D18488-91BB-402D-A69C-D88AD9F51287Q38715815-DE1697F2-2BEC-4AAB-9195-C72207291F93Q38964993-30EFB59E-2006-490B-9185-7E94B1C1F60EQ39141333-B9A3B24B-172E-44D9-83C9-F58D804165B7Q39544673-E2D1670C-0DDA-4BBE-BDFE-0E25B739DD60Q46446145-ACF0DDCC-E0BD-4068-8150-A2371FDF3B68Q46740099-82579461-18C1-47EB-9A2A-9F160340AC7FQ47179835-C9EEC115-0252-4B7D-9FAA-A2F2322D3F3EQ49592866-3BA9C027-EDB3-4DBB-8426-DA4822DC9CA4Q51778528-B52698AA-CF2B-4408-A382-05EFCF46270BQ53292207-FA6EA476-90D4-441C-80E6-ECBF7B392E4EQ58773583-C385283E-D322-4D93-BE7F-3F9064DD12D9
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cancer: Why tumours eat tryptophan.
@en
Cancer: Why tumours eat tryptophan.
@nl
type
label
Cancer: Why tumours eat tryptophan.
@en
Cancer: Why tumours eat tryptophan.
@nl
prefLabel
Cancer: Why tumours eat tryptophan.
@en
Cancer: Why tumours eat tryptophan.
@nl
P2860
P356
P1433
P1476
Cancer: Why tumours eat tryptophan.
@en
P2093
George C Prendergast
P2860
P2888
P304
P356
10.1038/478192A
P407
P577
2011-10-12T00:00:00Z
P5875
P6179
1049372777